InsidersTradesSigma
Track the OmniAb Operations, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 3 November 2022 (J). Among the most active insiders: LIGAND PHARMACEUTICALS INC. All data is free.
Analysts rate OmniAb Operations, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
OmniAb Operations, Inc. is a company listed on the XNAS market. It specializes in developing technologies for antibody discovery.